ASP Isotopes Sees Unusually High Options Volume (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of unusually large options trading on Tuesday. Investors purchased 3,973 call options on the stock. This is an increase of approximately 33% compared to the typical volume of 2,994 call options.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, COO Robert Ainscow sold 66,668 shares of the firm’s stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $374,674.16. Following the completion of the transaction, the chief operating officer now owns 1,419,992 shares of the company’s stock, valued at approximately $7,980,355.04. This trade represents a 4.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Paul Elliot Mann sold 316,666 shares of the company’s stock in a transaction that occurred on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $1,779,662.92. Following the completion of the sale, the chief executive officer now owns 7,315,454 shares in the company, valued at $41,112,851.48. The trade was a 4.15% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 766,667 shares of company stock valued at $4,358,502. Corporate insiders own 21.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently made changes to their positions in the company. Philadelphia Financial Management of San Francisco LLC boosted its holdings in shares of ASP Isotopes by 11.2% in the first quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company’s stock worth $16,453,000 after buying an additional 354,517 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after acquiring an additional 2,709 shares during the last quarter. Bosun Asset Management LLC bought a new stake in shares of ASP Isotopes during the 1st quarter valued at $103,000. AWM Investment Company Inc. increased its stake in shares of ASP Isotopes by 6.2% in the 1st quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company’s stock worth $21,157,000 after purchasing an additional 265,000 shares in the last quarter. Finally, Apis Capital Advisors LLC increased its stake in shares of ASP Isotopes by 10.7% in the 1st quarter. Apis Capital Advisors LLC now owns 191,000 shares of the company’s stock worth $896,000 after purchasing an additional 18,472 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Stock Performance

Shares of ASPI traded down $1.15 during trading hours on Tuesday, hitting $6.37. The stock had a trading volume of 5,074,855 shares, compared to its average volume of 2,441,518. The firm has a market capitalization of $478.22 million, a PE ratio of -10.46 and a beta of 3.40. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes has a 12 month low of $1.86 and a 12 month high of $9.33. The stock has a fifty day moving average price of $5.28 and a 200 day moving average price of $5.43.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.